Genfit S.A. (GNFTF)
OTCMKTS · Delayed Price · Currency is USD
3.720
+0.440 (13.41%)
At close: Jul 25, 2025
Genfit Employees
Genfit had 180 employees as of December 31, 2024. The number of employees increased by 21 or 13.21% compared to the previous year.
Employees
180
Change (1Y)
21
Growth (1Y)
13.21%
Revenue / Employee
$281,887
Profits / Employee
-$242,126
Market Cap
216.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 180 | 21 | 13.21% |
| Dec 31, 2023 | 159 | 11 | 7.43% |
| Dec 31, 2022 | 148 | 26 | 21.31% |
| Dec 31, 2021 | 122 | -8 | -6.15% |
| Dec 31, 2020 | 130 | -64 | -32.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| QT Imaging Holdings | 21 |
| CytoDyn | 13 |
Genfit News
- 17 days ago - Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero - Seeking Alpha
- 4 weeks ago - Genfit (GNFT): HC Wainwright & Co. Lowers Price Target To $7.00 | GNFT Stock News - GuruFocus
- 4 weeks ago - Genfit (GNFTF) Reports 41.7% Revenue Decline in First Half of 2025 - GuruFocus
- 4 weeks ago - Genfit S.A. GAAP EPS of -€0.20, revenue of €35.67M - Seeking Alpha
- 4 weeks ago - GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Earnings Scheduled For September 22, 2025 - Benzinga
- 5 weeks ago - GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD - GlobeNewsWire
- 3 months ago - Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire